These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 23619562

  • 41. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J.
    Diagn Pathol; 2015 Apr 09; 10():24. PubMed ID: 25890121
    [Abstract] [Full Text] [Related]

  • 42. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
    Jin S, Chen L, Wu J, Chen M, Wang H, Hu H, Yu L, Zeng S.
    Int J Immunopathol Pharmacol; 2023 Apr 09; 37():3946320231184997. PubMed ID: 37584255
    [Abstract] [Full Text] [Related]

  • 43. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
    Liu W, Li H, Wang Y, Zhao X, Guo Y, Jin J, Chi R.
    Gene; 2017 Aug 30; 626():275-281. PubMed ID: 28536082
    [Abstract] [Full Text] [Related]

  • 44. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X.
    BMC Cancer; 2012 Nov 23; 12():546. PubMed ID: 23173671
    [Abstract] [Full Text] [Related]

  • 45. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M, Enokida H.
    Cancer Sci; 2013 Nov 23; 104(11):1411-9. PubMed ID: 23889809
    [Abstract] [Full Text] [Related]

  • 46. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
    Oncology; 2019 Nov 23; 97(3):164-172. PubMed ID: 31195398
    [Abstract] [Full Text] [Related]

  • 47. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
    Wang C, Cai L, Liu J, Wang G, Li H, Wang X, Xu W, Ren M, Feng L, Liu P, Zhang C.
    Cell Physiol Biochem; 2017 Nov 23; 43(6):2405-2419. PubMed ID: 29073630
    [Abstract] [Full Text] [Related]

  • 48. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B, Zhou N, Hu T, Zhao W, Wu D, Wang S.
    J Cell Physiol; 2019 Aug 23; 234(8):13464-13480. PubMed ID: 30624782
    [Abstract] [Full Text] [Related]

  • 49. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
    Zhai W, Ma J, Zhu R, Xu C, Zhang J, Chen Y, Chen Z, Gong D, Zheng J, Chen C, Li S, Li B, Huang Y, Xue W, Zheng J.
    Br J Cancer; 2018 Aug 23; 119(5):591-604. PubMed ID: 30082686
    [Abstract] [Full Text] [Related]

  • 50. Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.
    Chen D, Li Y, Su Z, Yu Z, Yu W, Li Y, Gui Y, Yang S, Lai Y.
    Mol Med Rep; 2015 Feb 23; 11(2):1278-83. PubMed ID: 25370896
    [Abstract] [Full Text] [Related]

  • 51. Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.
    Liu Y, Fu W, Cao X, Li S, Xiong T, Zhang X, Wu X, Cheng L, Wei Y, Gao B.
    Comput Math Methods Med; 2021 Feb 23; 2021():5517747. PubMed ID: 34122615
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T, Seki N, Yamada Y, Yoshino H, Hidaka H, Chiyomaru T, Nohata N, Kinoshita T, Nakagawa M, Enokida H.
    Int J Oncol; 2012 Sep 23; 41(3):805-17. PubMed ID: 22766839
    [Abstract] [Full Text] [Related]

  • 54. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S, Ziqi W, Luyao Y, Xiangwei Z, Liang L, Yuwei L, Lechen L, Wanhai X.
    Biosci Rep; 2017 Jun 30; 37(3):. PubMed ID: 28465356
    [Abstract] [Full Text] [Related]

  • 55. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z, Wei X, Jin N, Wang Y, Zhao R, Hu Y, Yan W, Li J, Zhou Q.
    Artif Cells Nanomed Biotechnol; 2018 Dec 30; 46(8):1920-1925. PubMed ID: 29130345
    [Abstract] [Full Text] [Related]

  • 56. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C, Wang S, Ye ZQ, Chen ZQ.
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec 30; 36(6):852-858. PubMed ID: 27924503
    [Abstract] [Full Text] [Related]

  • 57. miR-21-5p serves as a promoter in renal cell carcinoma progression through ARHGAP24 downregulation.
    Meng B, Wang P, Zhao C, Yin G, Meng X, Li L, Cai S, Yan C.
    Environ Sci Pollut Res Int; 2022 Jun 30; 29(26):39985-39993. PubMed ID: 35112252
    [Abstract] [Full Text] [Related]

  • 58. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X, Li Z, Zhao L, Quan J, Zhou L, Xu J, Xu W, Guan X, Li H, Yang S, Gui Y, Lai Y.
    Oncol Rep; 2018 Nov 30; 40(5):3092-3101. PubMed ID: 30132566
    [Abstract] [Full Text] [Related]

  • 59. The long noncoding RNA EMBP1 inhibits the tumor suppressor miR-9-5p and promotes renal cell carcinoma tumorigenesis.
    Hong Y, Yuan Z, Huang R, Wu Z, Li Y.
    Nefrologia (Engl Ed); 2020 Nov 30; 40(4):429-439. PubMed ID: 32482375
    [Abstract] [Full Text] [Related]

  • 60. miR‑660‑5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma.
    He T, Chen P, Jin L, Hu J, Li Y, Zhou L, Yang S, Mao X, Gui Y, Chen Y, Lai Y.
    Mol Med Rep; 2018 Jan 30; 17(1):2051-2060. PubMed ID: 29138826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.